Strahlentherapie und Onkologie

, Volume 194, Issue 6, pp 600–601 | Cite as

Unterschiedliche Letalität nach Operation und stereotaktischer Strahlentherapie beim nicht-kleinzelligen Lungenkarzinom im Frühstadium

Literatur kommentiert
  • 35 Downloads

Different mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer

Notes

Interessenkonflikt

K.J. Borm und S.E. Combs geben an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Chang JY et al (2012) Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 7:152CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chang JY et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630–637CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Crabtree TD et al (2010) Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 140(2):377–386CrossRefPubMedGoogle Scholar
  4. 4.
    Palma D et al (2011) Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 101(2):240–244CrossRefPubMedGoogle Scholar
  5. 5.
    Shirvani SM et al (2014) Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg 149(12):1244–1253CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Verstegen NE et al (2013) Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24(6):1543–1548CrossRefPubMedGoogle Scholar
  7. 7.
    Videtic GMM et al (2017) Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 7(5):295–301CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Klinikum rechts der IsarTechnische UniversitätMünchenDeutschland

Personalised recommendations